Anemia as a Risk Factor for Kidney Function Decline in Individuals With Heart Failure††This study was presented in abstract form at the American Society of Nephrology meetings in 2005.

American Journal of Cardiology

Volumn 99, Issue 8, 2007, Pages 1137-1142

  Bansal, Nisha ^a   Tighiouart, Hocine ^a   Weiner, Daniel ^a   Griffith, John ^a   Vlagopoulos, Panagiotis ^a   Salem, Deeb ^a   Levin, Adeera ^b   Sarnak, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ENALAPRIL; PLACEBO;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEMATOCRIT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ANEMIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC OUTPUT, LOW; CHRONIC DISEASE; COHORT STUDIES; CREATININE; DIABETES COMPLICATIONS; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMATOCRIT; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; PLACEBOS; RISK FACTORS; STROKE VOLUME;

EID: 34147129280     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.11.055     Document Type: Article

References (29)

1. Herzog C.A., Muster H.A., Li S., and Collins A.J. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail 10 (2004) 467-472
2. Silverberg D.S., Wexler D., Blum M., Tchebiner J., Sheps D., Keren G., Schwartz D., Baruch R., Yachnin T., Shaked M., et al. The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. Clin Nephrol 58 suppl (2002) S37-S45
3. Anand I.S., Kuskowski M.A., Rector T.S., Florea V.G., Glazer R.D., Hester A., Chiang Y.T., Aknay N., Maggioni A.P., Opasich C., et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation 112 (2005) 1121-1127
4. Mancini D.M., Katz S.D., Lang C.C., LaManca J., Hudaihed A., and Androne A.S. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299
5. Al-Ahmad A., Rand W.M., Manjunath G., Konstam M.A., Salem D.N., Levey A.S., and Sarnak M.J. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38 (2001) 955-962
6. Levin A., Thompson C.R., Ethier J., Carlisle E.J., Tobe S., Mendelssohn D., Burgess E., Jindal K., Barrett B., Singer J., and Djurdjev O. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34 (1999) 125-134
7. Keane W.F., Brenner B.M., de Zeeuw D., Grunfeld J.P., McGill J., Mitch W.E., Ribeiro A.B., Shahinfar S., Simpson R.L., Snapinn S.M., and Toto R. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int 63 (2003) 1499-1507
8. Forman D.E., Butler J., Wang Y., Abraham W.T., O'Connor C.M., Gottlieb S.S., Loh E., Massie B.M., Rich M.W., Stevenson L.W., et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43 (2004) 61-67
9. Butler J., Forman D.E., Abraham W.T., Gottlieb S.S., Loh E., Massie B.M., O'Connor C.M., Rich M.W., Stevenson L.W., Wang Y., et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147 (2004) 331-338
10. Khan N.A., Ma I., Thompson C.R., Humphries K., Salem D.N., Sarnak M.J., and Levin A. Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol 17 (2006) 244-253
11. Vlagopoulos P.T., Tighiouart H., Weiner D.E., Griffith J., Pettitt D., Salem D.N., Levey A.S., and Sarnak M.J. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol 16 (2005) 3403-3410
12. Jurkovitz C.T., Abramson J.L., Vaccarino L.V., Weintraub W.S., and McClellan W.M. Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Nephrol 14 (2003) 2919-2925
13. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302.
14. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D., and Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Annals Int Med 130 (1999) 461-470
15. Gerson A., Hwang W., Fiorenza J., Barth K., Kaskel F., Weiss L., Zelikovsky N., Fivush B., and Furth S. Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis 44 (2004) 1017-1023
16. Hebert L.A., Greene T., Levey A., Falkenhain M.E., and Klahr S. High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis 41 (2003) 962-971
17. Wright Jr. J.T., Bakris G., Greene T., Agodoa L.Y., Appel L.J., Charleston J., Cheek D., Douglas-Baltimore J.G., Gassman J., Glassock R., et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288 (2002) 2421-2431
18. Klahr S. Role of dietary protein and blood pressure in the progression of renal disease. Kidney Int 49 (1996) 1783-1786
19. Gouva C., Nikolopoulos P., Ioannidis J.P., and Siamopoulos K.C. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 66 (2004) 753-760
20. Knight E.L., Glynn R.J., McIntyre K.M., Mogun H., and Avorn J. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the Studies of Left Ventricular Dysfunction (SOLVD). Am Heart J 138 (1999) 849-855
21. World Health Organization. Nutritional anaemias: a report of a WHO scientific group. World Health Organ Tech Rep Ser 405 (1968) 3-37
22. Silverberg D.S., Wexler D., Sheps D., Blum M., Keren G., Baruch R., Schwartz D., Yachnin T., Steinbruch S., Shapira I., et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 37 (2001) 1775-1780
23. Fine L.G., Bandyopadhay D., and Norman J.T. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria?. Towards the unifying theme of chronic hypoxia. Kidney Int Suppl 75 (2000) S22-S26
24. Orphanides C., Fine L.G., and Norman J.T. Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int 52 (1997) 637-647
25. Nangaku M. Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Nephron Exp Nephrol 98 (2004) e8-e12
26. Rossert J., Fouqueray B., and Boffa J.J. Anemia management and the delay of chronic renal failure progression. J Am Soc Nephrol 14 (2003) S173-S177
27. Katz A.M. The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart. Ann Intern Med 121 (1994) 363-371
28. Winkelmayer W.C., Kewalramani R., Rutstein M., Gabardi S., Vonvisger T., and Chandraker A. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol 15 (2004) 1347-1352
29. Albitar S., Genin R., Fen-Chong M., Serveaux M.O., and Bourgeon B. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients. Nephrol Dial Transplant 13 (1998) 1206-1210